POSA202 Occurrence of Cardiovascular-Related Hospitalization and Emergency Department (ED) Visits for Men with Prostate Cancer Initiating Systemic Androgen Deprivation Therapy (ADT) in the United States

Abstract

ADT with gonadotropin releasing hormone (GnRH) agonists or antagonists is the standard of care in men with advanced prostate cancer (PCa). GnRH agonists’ prescribing information include safety warnings of increased risk for some cardiovascular (CV) diseases. The association between GnRH agonists and cardiovascular (CV) events has been debated. This study examined time to CV-related hospitalization or ED visit for men diagnosed with PCa and treated with ADT.